Juanjuan Shan

2.6k total citations
41 papers, 2.1k citations indexed

About

Juanjuan Shan is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Juanjuan Shan has authored 41 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 19 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Juanjuan Shan's work include Cancer Cells and Metastasis (10 papers), MicroRNA in disease regulation (6 papers) and Sirtuins and Resveratrol in Medicine (6 papers). Juanjuan Shan is often cited by papers focused on Cancer Cells and Metastasis (10 papers), MicroRNA in disease regulation (6 papers) and Sirtuins and Resveratrol in Medicine (6 papers). Juanjuan Shan collaborates with scholars based in China, Spain and United States. Juanjuan Shan's co-authors include Cheng Qian, Zhi Yang, Yanmin Xu, Limei Liu, Junjie Shen, Chungang Liu, Xiu‐Wu Bian, Junjie Shen, You‐Hong Cui and X Y Feng and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Juanjuan Shan

37 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juanjuan Shan China 24 1.4k 735 635 208 191 41 2.1k
Qingguang Liu China 32 1.9k 1.3× 1.4k 1.9× 466 0.7× 182 0.9× 187 1.0× 67 2.7k
Yuxiong Feng China 18 1.0k 0.7× 469 0.6× 493 0.8× 328 1.6× 179 0.9× 35 1.8k
Yongjun Tan China 22 1.8k 1.3× 303 0.4× 447 0.7× 86 0.4× 209 1.1× 44 2.2k
Jen-Liang Su Taiwan 27 1.8k 1.3× 780 1.1× 863 1.4× 275 1.3× 32 0.2× 35 2.5k
Yulong Shang China 22 1.2k 0.8× 761 1.0× 309 0.5× 180 0.9× 112 0.6× 55 1.8k
Sunbin Ling China 19 790 0.6× 402 0.5× 533 0.8× 108 0.5× 232 1.2× 50 1.4k
Yongfu Zhao China 24 923 0.6× 529 0.7× 261 0.4× 301 1.4× 132 0.7× 60 1.5k
Daimin Xiang China 17 1.2k 0.8× 764 1.0× 301 0.5× 178 0.9× 268 1.4× 28 1.6k
Jessica E.S. Shay United States 11 903 0.6× 932 1.3× 183 0.3× 147 0.7× 54 0.3× 22 1.5k
Guangjie Duan China 15 642 0.5× 283 0.4× 360 0.6× 140 0.7× 53 0.3× 46 1.1k

Countries citing papers authored by Juanjuan Shan

Since Specialization
Citations

This map shows the geographic impact of Juanjuan Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juanjuan Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juanjuan Shan more than expected).

Fields of papers citing papers by Juanjuan Shan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juanjuan Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juanjuan Shan. The network helps show where Juanjuan Shan may publish in the future.

Co-authorship network of co-authors of Juanjuan Shan

This figure shows the co-authorship network connecting the top 25 collaborators of Juanjuan Shan. A scholar is included among the top collaborators of Juanjuan Shan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juanjuan Shan. Juanjuan Shan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shan, Juanjuan, Elias Rodríguez-Fos, Marc E. Healy, et al.. (2025). Extrachromosomal circular DNA promotes inflammation and hepatocellular carcinoma development. Science Advances. 11(42). eadw0272–eadw0272.
2.
Ye, Dan, et al.. (2025). Yin yang 1: a potential regulator of immune related diseases and cancer immunity. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(5). 189389–189389.
3.
Yang, Tongwang, et al.. (2025). Non-parenchymal cells: key targets for modulating chronic liver diseases. Frontiers in Immunology. 16. 1576739–1576739. 1 indexed citations
4.
Li, Ziyong, Yuanli Ni, Limei Liu, et al.. (2024). B cell lymphoma 6 promotes hepatocellular carcinoma progression by inhibiting tumor infiltrating CD4+T cell cytotoxicity through ESM1. npj Precision Oncology. 8(1). 139–139. 5 indexed citations
5.
Li, Ziyong, et al.. (2024). The Role of CD4+T Cells in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. International Journal of Molecular Sciences. 25(13). 6895–6895. 2 indexed citations
6.
Chen, Jun, et al.. (2023). Hypoxia-Responsive CAR-T Cells Exhibit Reduced Exhaustion and Enhanced Efficacy in Solid Tumors. Cancer Research. 84(1). 84–100. 44 indexed citations
7.
Wei, Zhihao, Jiatao Li, Juanjuan Shan, et al.. (2023). SIRT1 promotes glucolipid metabolic conversion to facilitate tumor development in colorectal carcinoma. International Journal of Biological Sciences. 19(6). 1925–1940. 31 indexed citations
8.
Xiang, Junyu, Ni Zhang, Hui Sun, et al.. (2019). Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells. Gastroenterology. 158(3). 664–678.e24. 83 indexed citations
9.
Liu, Chungang, Limei Liu, Xuejiao Chen, et al.. (2017). LSD1 Stimulates Cancer-Associated Fibroblasts to Drive Notch3-Dependent Self-Renewal of Liver Cancer Stem–like Cells. Cancer Research. 78(4). 938–949. 108 indexed citations
10.
Zhang, Qianzhen, Zhi Yang, Juanjuan Shan, et al.. (2017). MicroRNA-449a maintains self-renewal in liver cancer stem-like cells by targeting Tcf3. Oncotarget. 8(66). 110187–110200. 9 indexed citations
11.
Xiang, Junyu, Hui Sun, Li Su, et al.. (2017). Myocyte enhancer factor 2D promotes colorectal cancer angiogenesis downstream of hypoxia-inducible factor 1α. Cancer Letters. 400. 117–126. 28 indexed citations
12.
Su, Li, Yongli Luo, Zhi Yang, et al.. (2016). MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer. Cancer Research. 76(17). 5054–5067. 57 indexed citations
13.
Luo, Yongli, Zhi Yang, Li Su, et al.. (2016). Non-CSCs nourish CSCs through interleukin-17E-mediated activation of NF-κB and JAK/STAT3 signaling in human hepatocellular carcinoma. Cancer Letters. 375(2). 390–399. 38 indexed citations
14.
Cheng, Jiamin, Chungang Liu, Limei Liu, et al.. (2016). MEK1 signaling promotes self-renewal and tumorigenicity of liver cancer stem cells via maintaining SIRT1 protein stabilization. Oncotarget. 7(15). 20597–20611. 21 indexed citations
15.
Xu, Yanmin, Leina Ma, Juanjuan Shan, et al.. (2015). MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways. Cancer Letters. 371(2). 171–181. 135 indexed citations
16.
Ma, Leina, Jia Liu, Limei Liu, et al.. (2014). Overexpression of the Transcription Factor MEF2D in Hepatocellular Carcinoma Sustains Malignant Character by Suppressing G2–M Transition Genes. Cancer Research. 74(5). 1452–1462. 74 indexed citations
17.
Liu, Chungang, Limei Liu, Juanjuan Shan, et al.. (2013). Histone deacetylase 3 participates in self-renewal of liver cancer stem cells through histone modification. Cancer Letters. 339(1). 60–69. 66 indexed citations
18.
Liu, Chungang, Limei Liu, Xuejiao Chen, et al.. (2013). Decrease of 5-Hydroxymethylcytosine Is Associated with Progression of Hepatocellular Carcinoma through Downregulation of TET1. PLoS ONE. 8(5). e62828–e62828. 141 indexed citations
19.
Yang, Zhi, Qianzhen Zhang, Juanjuan Shan, et al.. (2012). Combined Therapy with Cytokine-Induced Killer Cells and Oncolytic Adenovirus Expressing IL-12 Induce Enhanced Antitumor Activity in Liver Tumor Model. PLoS ONE. 7(9). e44802–e44802. 45 indexed citations
20.
Hu, Jie, Aiwen Dong, Juanjuan Shan, et al.. (2009). Blockade of Wnt Signaling Inhibits Angiogenesis and Tumor Growth in Hepatocellular Carcinoma. Cancer Research. 69(17). 6951–6959. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026